⚡ CPB trust restated after 36 years; $384.7M Dorrance Malone…
Published May 26, 2026
We read 597 filings today. Here are the ones worth your time.
433 Form 4164 8-K8 Buys147 Sells
Someone at Exxon Mobil just moved $276.6 million worth of XOM stock. That's the largest insider transaction we've tracked in months.
Five directors stepped in with their own cash this week: CDW's Leahy made a purchase, Norwegian Cruise saw two buys from Cohen and CEO Cil, Boeing's Tilden bought BA, and Boston Scientific's Habiger added BSX. Meanwhile, 147 insiders were selling across 597 filings.
ExxonMobil's CEO sold $276.6M of XOM this week. Discretionary. The stock sits near the middle of its 52-week range at $154.92, off 12% from its January high of $176. Brent crude is up 85% since January, but oil sank 5% this week on Iran truce speculation. He sold into that.
Here's the tension. Energy executives usually load up when crude rallies. This one walked the other direction with a nine-figure exit while his peers sit tight. XOM beat earnings by 12% last quarter, but the sector's riding geopolitical swings now, not fundamentals. The CEO knows what the next print looks like. He sold anyway.
Director Leahy just bought $499K of CDW at $111, a discretionary purchase in the middle of the 52-week range. The stock is down 40% from its peak as IT spending remains sluggish, but the entry point suggests she sees value before it fully recovers. She added 2.4% to her position while the company trades at enterprise multiples well below historical averages.
Board member Cohen just bought $475K of NCLH at $16.30, discretionary and not pre-planned. The stock sits near its 52-week low of $15 while a securities fraud investigation looms over the company. Cohen now owns 43.5% more shares than he did before this purchase.
Board member Cil just bought $451K of NCLH at $16.30, less than 10% above the 52-week low. The discretionary purchase comes as the stock trades down 40% from its highs amid a fraud investigation notice. He now holds 32% more shares than before the buy.
Boeing board member Tilden bought $299K of BA at $219, discretionary and not pre-planned. The stock sits mid-range after a volatile year marked by production issues and the 737 MAX crisis. He increased his position by 50% while Boeing works through regulatory scrutiny and a massive backlog.
Board member Habiger just bought $251K of BSX at $57.78, a discretionary purchase near the 52-week low of $53. The stock has cratered 48% from its $110 peak despite Boston Scientific closing a $1.5B deal to expand in aortic stenosis treatment. He's buying into weakness while the market processes the acquisition's impact on margins.
Chevron director John Hess just sold $73.4M worth of shares at $191, cutting his position by 58%. Discretionary sale, not pre-planned. He dumped more than half his stake while oil hovers near year-to-date highs and his CEO warns that supply buffers are thinning.
CVX $191.43 . 52w: $135-$215 . +0% YTD
THE TAPE
MPWR
Maurice Sciammas sells $18.7M of MPWR
CPAY
CEO Ronald Clarke exercises options in $15.1M of CPAY
HAL
Van Beckwith sells $8.2M of HAL
CRWD
Sameer Gandhi sells $7.5M of CRWD
ABNB
Joseph Gebbia sells $7.3M of ABNB
AIZ
CFO Keith Meier sells $6.4M of AIZ
AFL
Japan Post Holdings Co., Ltd sells $5.9M of AFL
HSY
Hershey Trust CO Trustee IN Trust For Milton Hershey School sells $5.7M of HSY
Akamai issued $1.15B in convertible senior notes due 2030 and used the proceeds to repurchase $750M of its 2025 notes early, refinancing debt at better terms while extending its maturity profile. The convertible structure gives bondholders equity upside above $191 per share, roughly 30% above current levels. With the stock trading near 52-week highs after a 110% run from its lows, the company is locking in financing costs while its valuation supports the conversion premium.
Corpay locked in a material agreement and issued an FD disclosure, suggesting something substantive enough to trigger regulatory reporting but not material enough for a full press release. The timing is curious given CPAY is trading near 52-week highs after a flat year, often when companies make strategic moves from a position of strength. The agreement details matter here, watch for follow-up commentary on the next earnings call.
Akamai locked in $1.2B of new senior notes due 2032 and 2035, pricing at investment-grade spreads while its stock sits near all-time highs. The debt raise comes as the CDN giant shifts toward higher-margin security and compute services. Capital costs are favorable now, and management is locking them in before the market shifts.